Literature DB >> 25745638

Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells.

Jinbo Fang1, Huali Xu1, Chunshu Yang1, Sharif Morsalin1, Shubhalaxmi Kayarthodi1, Kunchala Rungsrisuriyachai1, Ujwala Gunnal2, Brittany Mckenzie1, Veena N Rao1, E Shyam P Reddy1.   

Abstract

TGF-β/Smads signaling plays a significant role in the regulation of growth of normal and prostate cancer cells. Smad proteins function as important mediators of intracellular signal transduction of transforming growth factor-β (TGF-β). TGF-β signaling pathway is known to regulate cell proliferation, differentiation, apoptosis and play a major role in some human diseases and cancers. Following their phosphorylation by TGF-β receptor-I, Receptor-regulated Smads (including Smad2 and Smad3 proteins) form a heteromeric complex with co-Smad (Smad4) and then translocate into the nucleus where they bind and regulate the expression of target genes. ERG (Ets Related Gene) belongs to the ETS family of transcriptional factors. Chromosomal rearrangement of TMPRSS2 gene and ERG gene has been found in majority of prostate cancers. Over-expression of full length or truncated ERG proteins have been shown to associate with a higher rate of recurrent and unfavorable prognosis of prostate cancer. In order to understand how ERG oncoprotein regulates TGF-β/Smads signaling pathway, we have studied the effect of ERG on TGF-β/Smad3 signaling pathway. In this study, we demonstrate that ERG oncoprotein physically interacts with Smad3 protein and stabilizes phospho-Smad3 protein and thereby enhance TGF-β/Smad3 signaling pathway in prostate cells. Thus, ERG oncoprotein plays an important role in prostate tumorigenesis by using a novel mechanism to activate TGF-β/Smad3 signaling pathway.

Entities:  

Keywords:  ERG; Phosphorylation; Prostate Cancer; Smad Protein; TGF-β

Year:  2014        PMID: 25745638      PMCID: PMC4347898          DOI: 10.1166/jpsp.2014.1022

Source DB:  PubMed          Journal:  J Pharm Sci Pharmacol


  35 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  The human erg gene maps to chromosome 21, band q22: relationship to the 8; 21 translocation of acute myelogenous leukemia.

Authors:  V N Rao; W S Modi; H D Drabkin; D Patterson; S J O'Brien; T S Papas; E S Reddy
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

Review 3.  Specificity and versatility in tgf-beta signaling through Smads.

Authors:  Xin-Hua Feng; Rik Derynck
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

4.  Role of transforming growth factor-beta signaling in cancer.

Authors:  M P de Caestecker; E Piek; A B Roberts
Journal:  J Natl Cancer Inst       Date:  2000-09-06       Impact factor: 13.506

5.  Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.

Authors:  Fayth L Miles; Navpreet S Tung; Adam A Aguiar; Senem Kurtoglu; Robert A Sikes
Journal:  Prostate       Date:  2012-01-06       Impact factor: 4.104

6.  Promotion and maintenance of leukemia by ERG.

Authors:  Shinobu Tsuzuki; Osamu Taguchi; Masao Seto
Journal:  Blood       Date:  2011-02-14       Impact factor: 22.113

7.  ETS gene fusions and prostate cancer.

Authors:  Wei Huang; Michelle Waknitz
Journal:  Am J Transl Res       Date:  2009-05-25       Impact factor: 4.060

8.  Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.

Authors:  Bungo Furusato; Chun-Ling Gao; Lakshmi Ravindranath; Yongmei Chen; Jennifer Cullen; David G McLeod; Albert Dobi; Shiv Srivastava; Gyorgy Petrovics; Isabell A Sesterhenn
Journal:  Mod Pathol       Date:  2007-12-07       Impact factor: 7.842

9.  erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation.

Authors:  V N Rao; T S Papas; E S Reddy
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

10.  Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.

Authors:  Lihong Yin; Pravin Rao; Paul Elson; Jianghua Wang; Michael Ittmann; Warren D W Heston
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

View more
  7 in total

1.  Novel EWSR1-SMAD3 Gene Fusions in a Group of Acral Fibroblastic Spindle Cell Neoplasms.

Authors:  Yu-Chien Kao; Uta Flucke; Astrid Eijkelenboom; Lei Zhang; Yun-Shao Sung; Albert J H Suurmeijer; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-04       Impact factor: 6.394

2.  Molecular Mechanism of β-Catenin Signaling Pathway Inactivation in ETV1-Positive Prostate Cancers.

Authors:  Sharif Morsalin; Chunshu Yang; Jinbo Fang; Sampreet Reddy; Shubhalaxmi Kayarthodi; Ed Childs; Roland Matthews; Veena N Rao; E Shyam P Reddy
Journal:  J Pharm Sci Pharmacol       Date:  2015-09

3.  The role and gene expression profile of SOCS3 in colorectal carcinoma.

Authors:  Xing Dong; Jing Wang; Bo Tang; Yeng-Xue Hao; Ping-Yang Li; Shi-Yong Li; Pei-Wu Yu
Journal:  Oncotarget       Date:  2017-12-20

4.  Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.

Authors:  Frank Jacobsen; Juliane Kraft; Cornelia Schroeder; Claudia Hube-Magg; Martina Kluth; Dagmar S Lang; Ronald Simon; Guido Sauter; Jakob R Izbicki; Till S Clauditz; Andreas M Luebke; Andrea Hinsch; Waldemar Wilczak; Corinna Wittmer; Franziska Büscheck; Doris Höflmayer; Sarah Minner; Maria Christina Tsourlakis; Hartwig Huland; Markus Graefen; Lars Budäus; Imke Thederan; Georg Salomon; Thorsten Schlomm; Nathaniel Melling
Journal:  Neoplasia       Date:  2017-08-19       Impact factor: 5.715

5.  Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate Cancer.

Authors:  Sangphil Oh; Sook Shin; Hoogeun Song; Joseph P Grande; Ralf Janknecht
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

6.  MicroRNA-29b inhibits human vascular smooth muscle cell proliferation via targeting the TGF-β/Smad3 signaling pathway.

Authors:  Lirong Li; Shaohua Ren; Xudong Hao; Zigang Zhen; Lei Ji; Hongming Ji
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

7.  Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.

Authors:  Neil P Dufton; Claire R Peghaire; Lourdes Osuna-Almagro; Claudio Raimondi; Viktoria Kalna; Abhishek Chauhan; Gwilym Webb; Youwen Yang; Graeme M Birdsey; Patricia Lalor; Justin C Mason; David H Adams; Anna M Randi
Journal:  Nat Commun       Date:  2017-10-12       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.